Streetbeat News

Products Services

GM

General Motors plans to launch an all-electric Cadillac Escalade, Escalade IQ, later this year as part of its plan to convert Cadillac into an electric vehicle brand by 2030. GM aims to produce 50,000 vehicles by H1 2023 and is investing $35 billion in EVs and autonomous vehicles between 2020 and 2025.

Portfolio Pulse from Lekha Gupta

May 22, 2023 | 6:58 pm

RIVN

Rivian Automotive (RIVN) shares are trading higher by 5.46% amid strength in growth stocks and hopes of a debt ceiling resolution. The company announced that its all-electric service vans will hit the roads in the coming weeks, with over 200 Rivian Service Vans (RSV) expected by year-end.

Portfolio Pulse from Henry Khederian

May 22, 2023 | 6:52 pm

AMZN

Kevin Pak, an Amazon seller who made $127,000 in profit in 2022, shares tips for getting products listed on the first page of Amazon. Strategies include using high-quality images, search-engine-optimized keywords, avoiding changes to titles and images after launch, running paid-per-click advertising campaigns, and pricing products competitively.

Portfolio Pulse from Bibhu Pattnaik

May 22, 2023 | 6:43 pm

JNJ

RAIN

Rain Oncology announced disappointing Phase 3 MANTRA data for milademetan in patients with dedifferentiated liposarcoma, failing to meet its primary endpoint. The company does not expect to pursue further development of milademetan, causing RAIN shares to plummet 86.9%.

Portfolio Pulse from Vandana Singh

May 22, 2023 | 6:36 pm

RIVN

Rivian shares are trading higher as growth stocks gain strength. The company announced that its all-electric service vans will be on the roads in the coming weeks.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 6:32 pm

PYPL

PayPal's shares are trading higher following the introduction of teen accounts for its subsidiary, Venmo.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 6:30 pm

LLY

NVO

PFE

Pfizer's oral weight loss drug danuglipron may be as effective as Novo Nordisk's Ozempic injection, according to a study of phase 2 clinical trial results. The study suggests that danuglipron works quicker and results in a similar amount of weight loss as Ozempic, with the advantage of being orally administered.

Portfolio Pulse from Adam Eckert

May 22, 2023 | 6:23 pm

NURO

NeuroMetrix has been granted European Patent Number EP3538202 for its novel unbalanced biphasic waveform and electrode arrangement in transcutaneous electrical nerve stimulation.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 6:16 pm

NVO

Novo Nordisk announced positive results from its OASIS 1 Phase 3a trial for oral semaglutide 50 mg, a weight management drug. The trial showed statistically significant and superior weight loss compared to placebo. The company plans to file for regulatory approval in the US and EU in 2023.

Portfolio Pulse from Vandana Singh

May 22, 2023 | 6:08 pm

MDT

Medtronic announced longer-term follow-up results of its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) System, designed to treat dangerously fast heart rhythms. The study found that 6.8% of patients experienced appropriate therapy by 18 months, with a 100% success rate in terminating treated shocks.

Portfolio Pulse from Vandana Singh

May 22, 2023 | 5:58 pm